Antidepressant azaheterocyclylmethyl derivatives of heterocycle-fused benzodioxans
CA 2498134 A1 · Owner: Wyeth · Inventors: Zhou, Dahui; Stack, Gary Paul
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compounds of the Formula: are useful for the treatment of depression (including but not limited to major depressive disorder childhood depression , and dysthymia), anxiety panic disorder, post-traumatic stress disorder premenstrual dysphoric disorder (also known as premenstrual syndrome) attention deficit disorder (with and without hyperactivity) obsessive , compulsive disorder, social anxiety disorder generalized anxiety disorder, obesity, eating disorders such as anorexia nervosa and bulimia nervosa vasomotor flushing, cocaine and alcohol addiction sexual dysfunction and , related illnesses.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 11, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 11, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 11, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.